Principal Scientist, TechBio Discovery

United Kingdom
3 weeks ago
£198,000 – £271,700 pa

Salary

£198,000 – £271,700 pa

Job Type
Permanent
Work Pattern
Full-time
Work Location
Hybrid
Seniority
Lead
Education
Phd
Posted
24 Apr 2026 (3 weeks ago)

Benefits

Annual bonus Equity compensation Comprehensive benefits package

Your work will change lives. Including your own.

The Impact You'll Make

Recursion is at the forefront of reimagining drug discovery by integrating technological innovations across biology, chemistry, automation, data science, and engineering to radically improve lives by industrializing drug discovery. We are seeking an experienced Associate Director to join our Discovery Biology team to lead and advance our AI-driven portfolio of therapeutic candidates.

This is a truly unique opportunity to work at the dynamic intersection of technology and biology. You won't just manage projects and key initiatives; you will be an active catalyst contributing to the evolution of a new, powerful paradigm in medicine.

In this Role, You Will:

  • Play a critical role in defining and executing our oncology strategy, seamlessly integrating traditional drug discovery principles with cutting-edgein silico computational approaches.
  • Lead scientific initiatives focused on successfully delivering various small molecule programs from initial hit to candidate selection and IND submission.
  • Contributeto novel target insight generation, patient refinement and patient selection strategies within several early discovery programs and have the opportunity to improve the Recursion OS itself.

The Team You'll Join

You will be an integral part of the Discovery team, working collaboratively with a diverse group of life scientists, computational and technical experts. You will work cross-functionally with team members from various disciplines, including data science, computational biology, pharmacology, DMPK, and chemistry, to accelerate the progression of compounds through the portfolio. This team is responsible for guiding the foundational biology and the critical "tech-to-program" translation across our early Discovery oncology portfolio.

The Experience You'll Need

  • PhD in a relevant biological science discipline (e.g., Molecular Biology, Oncology, Pharmacology, Biochemistry, Computational Biology) with at least 7+ years of experience in Tech-forward Biotech or Pharma
  • A proven track record of accomplishments in drug discovery, with specific experience in operating as a Scientific Team Lead for oncology and/or immuno-oncology programs from early discovery to a clinical candidate stage
  • Demonstrated experience with modern drug discovery approaches, including familiarity with AI/ML-driven platforms and models, high-throughput screening, ‘omics data analysis, with a systems biology mindset.
  • Strong understanding of the oncology landscape, including key therapeutic modalities, emerging targets, and clinical development challenges.
  • Exceptional leadership and interpersonal skills, with the ability to lead and motivate high-performing, cross-functional teams in a fast-paced, matrix environment.
  • Demonstrated ability to deliver impactful, clear presentations and memos to a wide range of audiences, including the Executive Leadership Team (ELT), program teams, Key Opinion Leaders (KOLs), and external partners.A strategic and tactical thinker who can prioritize competing demands and solve complex problems with a solution-focused mindset.

Working Location:

This is an office-based, hybrid role in ourSalt Lake City / New York Cityoffice. Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is$198,000 - $271,700 (USD). You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

#LI-EP1

The Values We Hope You Share:

  • We act boldly with integrity.We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
  • We care deeply and engage directly.Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
  • We learn actively and adapt rapidly.Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
  • We move with urgency because patients are waiting.Speed isn’t about rushing but about moving the needle every day.
  • We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
  • We are One Recursion.True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.


Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Related Jobs

View all jobs
Spotlight

Senior Director, Global Clinical Program Lead, Immunoglobulin

CSL
Spotlight

Director Biostatistics - Hematology

CSL

Principal Scientist, TechBio Discovery

Recursion North Tyneside, NE29 8EP, United Kingdom
US$198,000 – US$271,700 pa Hybrid

Associate Principal Computational Biologist, Neuroscience

Recursion United Kingdom

Principal Scientist

GSK Stevenage, United Kingdom
Hybrid

Principal Scientist, Genomics Analytics Engineer

GSK Stevenage, United Kingdom
Hybrid

Principal Scientist, Innovation ETCT

GSK Stevenage, United Kingdom
Hybrid

Computational Biologist

GSK Stevenage, United Kingdom
Hybrid

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Where to advertise biotech jobs UK in 2026: the specialist boards, academic networks and trade channels that reach biotech R&D and bioprocessing talent. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotech Jobs UK 2026: roles, salaries and the genomics, cell therapy and AI-driven drug discovery hiring trends shaping UK biotech careers. Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.

New Biotech Employers to Watch in 2026: UK and Global Companies Transforming Life Sciences Careers

New Biotech Employers to Watch in 2026: a UK and global shortlist of life sciences companies hiring genomics, cell therapy and clinical development talent. The biotechnology job market in the UK is entering a new phase—one defined by scientific breakthroughs, targeted investment, and a growing pipeline of innovative employers. For professionals browsing BiotechnologyJobs.co.uk, the key question is no longer just which companies exist, but which ones are scaling, hiring, and shaping the future of life sciences. In this article, we explore the new biotech employers to watch in 2026, focusing on UK-based startups, scale-ups, and international firms with a growing UK presence. These organisations have recently secured funding, partnerships, or strategic backing—strong indicators of hiring momentum in the months ahead.